Work in Progress Meetings
These meetings are an opportunity for trainees to present their ongoing research in a supportive environment, share and receive feedback, and learn
about exciting science in the community!
For the Winter 2025/26 term, virtual sessions are held weekly on Wednesdays, 3-4pm throughout January to May 2026. | View the schedule here >
Interested in presenting your work?
2025-26
UPCOMING SESSIONS
Apr 1
Claire Sie | PhD Student, Tropini Lab, Department of Microbiology & Immunology, UBC
Microbial modulation of the stress axis and endocrine development in inflammatory bowel disease
Imogen Porter | PhD Student, Tropini Lab, Genome Science & Technology, UBC
High-throughput screens of the gut microbiota for pathogen inhibition
RECENT SESSIONS
Mar 25
Lily Bertolo | PhD Student, Sun Lab, Department of Microbiology and Immunology, UBC
Acidification inhibitors as adjunctive therapy for intracellular bacterial infections
Katia Rosenflanz | Ma Lab, School of Biomedical Engineering, UBC
A nanoparticle-based assay for multidimensional immune cell characterization
Mar 18
Juliana Montoya Sanchez | PhD Student, Ciernia Lab, Department of Biochemistry and Molecular Biology, UBC
Developing Next-Generation RNA Delivery Approaches to Microglia
Natalie Stewart | PhD Student, Wisnovsky Lab, Faculty of Pharmaceutical Sciences, UBC
The glyco-immune checkpoint receptor Siglec-7 interacts with T cell ligands to regulate T cell activation and signaling
Mar 11
Lidia Piatnitca | PhD Student, Wisnovsky Lab, Faculty of Pharmaceutical Sciences, UBC
CRISPR activation screens map the genomic landscape of cancer glycome remodeling
Grace Kuo | PhD Student, McNagny Lab, School of Biomedical Engineering, UBC
Pluripotent stem cell-derived Type 2 innate lymphoid cells exhibit potent antitumor activity against pancreatic cancer cells
Mar 4
Nasim Ghavami Nodeh | Post-doc, Reid Lab, Department of Pediatrics, UBC
Enhancing Pediatric Solid Tumor Immunotherapy: GD2-CAR-T Cells and Radiolabeled Antibody Strategies for Neuroblastoma
Tae Kim | PhD Student, McNagny Lab, School of Biomedical Engineering, UBC
A microbiome metabolite suppresses pathogenic T cells in a corticosteroid-insensitive severe asthma



© Copyright 2025 by ImmunoT & ImmunoE